Assenagon Asset Management S.A. Purchases Shares of 5,224 ICU Medical, Inc. $ICUI

Assenagon Asset Management S.A. purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 5,224 shares of the medical instruments supplier’s stock, valued at approximately $745,000.

A number of other institutional investors have also made changes to their positions in ICUI. Millennium Management LLC lifted its position in shares of ICU Medical by 173.4% during the 3rd quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after purchasing an additional 690,694 shares during the last quarter. Norges Bank acquired a new position in shares of ICU Medical during the second quarter worth approximately $36,633,000. UBS Group AG lifted its holdings in shares of ICU Medical by 239.8% during the third quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier’s stock worth $46,371,000 after buying an additional 272,782 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of ICU Medical by 34.0% in the third quarter. Ameriprise Financial Inc. now owns 803,542 shares of the medical instruments supplier’s stock valued at $96,393,000 after acquiring an additional 203,746 shares during the period. Finally, Schroder Investment Management Group boosted its position in shares of ICU Medical by 25.2% in the third quarter. Schroder Investment Management Group now owns 796,704 shares of the medical instruments supplier’s stock valued at $93,246,000 after acquiring an additional 160,380 shares during the period. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Stock Down 3.0%

Shares of ICUI opened at $125.22 on Thursday. The company has a quick ratio of 1.15, a current ratio of 2.39 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average price of $141.65 and a two-hundred day moving average price of $137.94. The stock has a market cap of $3.13 billion, a price-to-earnings ratio of 6,264.13, a P/E/G ratio of 1.86 and a beta of 0.85. ICU Medical, Inc. has a 12 month low of $107.00 and a 12 month high of $160.29.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, February 19th. The medical instruments supplier reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.68 by $0.23. The company had revenue of $535.94 million for the quarter, compared to analyst estimates of $541.20 million. ICU Medical had a return on equity of 7.33% and a net margin of 0.03%.The company’s revenue was down 14.1% compared to the same quarter last year. During the same period in the prior year, the company posted $2.11 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Equities analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. KeyCorp boosted their target price on shares of ICU Medical from $175.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday, February 20th. Piper Sandler increased their price target on shares of ICU Medical from $172.00 to $178.00 and gave the company an “overweight” rating in a report on Friday, February 20th. Weiss Ratings restated a “sell (d-)” rating on shares of ICU Medical in a research note on Thursday, January 22nd. Finally, Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, ICU Medical presently has an average rating of “Moderate Buy” and an average price target of $179.33.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.